Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 257

1.

Educational Recommendations on Selected Analytical and Clinical Aspects of Natriuretic Peptides with a Focus on Heart Failure: A Report from the IFCC Committee on Clinical Applications of Cardiac Biomarkers.

Kavsak PA, Lam CSP, Saenger AK, Jaffe AS, Collinson P, Pulkki K, Omland T, Lefèvre G, Body R, Ordonez-Llanos J, Apple FS.

Clin Chem. 2019 Aug 6. pii: clinchem.2019.306621. doi: 10.1373/clinchem.2019.306621. [Epub ahead of print]

PMID:
31387884
2.

Aiming toWards Evidence baSed inTerpretation of Cardiac biOmarkers in patients pResenting with chest pain-the WESTCOR study: study design.

Tjora HL, Steiro OT, Langørgen J, Bjørneklett R, Nygård OK, Renstrøm R, Skadberg Ø, Bonarjee VVS, Lindahl B, Collinson P, Omland T, Vikenes K, Aakre KM.

Scand Cardiovasc J. 2019 Jul 1:1-6. doi: 10.1080/14017431.2019.1634280. [Epub ahead of print]

PMID:
31216908
3.

Troponin in Suspected Coronary Artery Disease: Headed Toward a New Paradigm in Cardiac Biomarkers?

Collinson P.

J Am Coll Cardiol. 2019 Jan 29;73(3):261-263. doi: 10.1016/j.jacc.2018.11.020. No abstract available.

PMID:
30678754
4.

How Does the Analytical Quality of the High-Sensitivity Cardiac Troponin T Assay Affect the ESC Rule Out Algorithm for NSTEMI?

Haagensen K, Collinson P, Åsberg A, Aakre KM.

Clin Chem. 2019 Mar;65(3):494-496. doi: 10.1373/clinchem.2018.298703. Epub 2019 Jan 15. No abstract available.

PMID:
30647124
5.

High sensitivity, contemporary and point-of-care cardiac troponin assays: educational aids developed by the IFCC Committee on Clinical Application of Cardiac Bio-Markers.

Collinson PO, Saenger AK, Apple FS; IFCC C-CB.

Clin Chem Lab Med. 2019 Apr 24;57(5):623-632. doi: 10.1515/cclm-2018-1211.

6.

Cardiac troponin and natriuretic peptide analytical interferences from hemolysis and biotin: educational aids from the IFCC Committee on Cardiac Biomarkers (IFCC C-CB).

Saenger AK, Jaffe AS, Body R, Collinson PO, Kavsak PA, Lam CSP, Lefèvre G, Omland T, Ordóñez-Llanos J, Pulkki K, Apple FS.

Clin Chem Lab Med. 2019 Apr 24;57(5):633-640. doi: 10.1515/cclm-2018-0905.

7.

High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial.

Shah ASV, Anand A, Strachan FE, Ferry AV, Lee KK, Chapman AR, Sandeman D, Stables CL, Adamson PD, Andrews JPM, Anwar MS, Hung J, Moss AJ, O'Brien R, Berry C, Findlay I, Walker S, Cruickshank A, Reid A, Gray A, Collinson PO, Apple FS, McAllister DA, Maguire D, Fox KAA, Newby DE, Tuck C, Harkess R, Parker RA, Keerie C, Weir CJ, Mills NL; High-STEACS Investigators.

Lancet. 2018 Sep 15;392(10151):919-928. doi: 10.1016/S0140-6736(18)31923-8. Epub 2018 Aug 28.

8.

Too much of a good thing - the over requesting of cardiac troponin.

Collinson P.

Ann Clin Biochem. 2018 Sep;55(5):522-524. doi: 10.1177/0004563218776027. Epub 2018 May 30. No abstract available.

PMID:
29848039
9.

Troponin, delta change and the evolution of cardiac biomarkers - back to the future (again).

Collinson P.

Ann Clin Biochem. 2018 Nov;55(6):626-629. doi: 10.1177/0004563218774809. Epub 2018 Apr 27. No abstract available.

PMID:
29703102
10.

Troponin measurement in patients with suspected acute coronary syndromes: walking beyond the wall.

Collinson P.

Eur Heart J Qual Care Clin Outcomes. 2018 Jan 1;4(1):8-9. doi: 10.1093/ehjqcco/qcx034. No abstract available.

PMID:
29045628
11.

Early diagnosis of acute coronary syndrome.

Katus H, Ziegler A, Ekinci O, Giannitsis E, Stough WG, Achenbach S, Blankenberg S, Brueckmann M, Collinson P, Comaniciu D, Crea F, Dinh W, Ducrocq G, Flachskampf FA, Fox KAA, Friedrich MG, Hebert KA, Himmelmann A, Hlatky M, Lautsch D, Lindahl B, Lindholm D, Mills NL, Minotti G, Möckel M, Omland T, Semjonow V.

Eur Heart J. 2017 Nov 1;38(41):3049-3055. doi: 10.1093/eurheartj/ehx492.

PMID:
29029109
12.

Cardiac troponins: from myocardial infarction to chronic disease.

Park KC, Gaze DC, Collinson PO, Marber MS.

Cardiovasc Res. 2017 Dec 1;113(14):1708-1718. doi: 10.1093/cvr/cvx183. Review.

13.

Laboratory Medicine is Faced with the Evolution of Medical Practice.

Collinson P.

J Med Biochem. 2017 Jul 14;36(3):211-215. doi: 10.1515/jomb-2017-0032. eCollection 2017 Sep. Review.

14.

Rapid Rule-out of Acute Myocardial Infarction With a Single High-Sensitivity Cardiac Troponin T Measurement Below the Limit of Detection: A Collaborative Meta-analysis.

Pickering JW, Than MP, Cullen L, Aldous S, Ter Avest E, Body R, Carlton EW, Collinson P, Dupuy AM, Ekelund U, Eggers KM, Florkowski CM, Freund Y, George P, Goodacre S, Greenslade JH, Jaffe AS, Lord SJ, Mokhtari A, Mueller C, Munro A, Mustapha S, Parsonage W, Peacock WF, Pemberton C, Richards AM, Sanchis J, Staub LP, Troughton R, Twerenbold R, Wildi K, Young J.

Ann Intern Med. 2017 May 16;166(10):715-724. doi: 10.7326/M16-2562. Epub 2017 Apr 18. Erratum in: Ann Intern Med. 2017 Oct 3;167(7):528.

15.

Erectile dysfunction and cardiovascular disease: a suitable case for treatment and prevention?

Collinson P.

Heart. 2017 Aug;103(16):1231-1232. doi: 10.1136/heartjnl-2017-311296. Epub 2017 Mar 10. No abstract available.

PMID:
28283536
16.

Should the 1h algorithm for rule in and rule out of acute myocardial infarction be used universally?

Crea F, Jaffe AS, Collinson PO, Hamm CW, Lindahl B, Mills NL, Thygesen K, Mueller C, Patrono C, Roffi M; 2015 ESC NSTE-ACS Guidelines Task Force.

Eur Heart J. 2016 Nov 21;37(44):3316-3323. doi: 10.1093/eurheartj/ehw282. No abstract available.

PMID:
28007934
17.

Cardiac Troponin Release is Associated with Biomarkers of Inflammation and Ventricular Dilatation During Critical Illness.

Ostermann M, Ayis S, Tuddenham E, Lo J, Lei K, Smith J, Sanderson B, Moran C, Collinson P, Peacock J, Rhodes A, Treacher D.

Shock. 2017 Jun;47(6):702-708. doi: 10.1097/SHK.0000000000000811.

18.

The interaction between systemic inflammation and psychosocial stress in the association with cardiac troponin elevation: A new approach to risk assessment and disease prevention.

Lazzarino AI, Hamer M, Gaze D, Collinson P, Rumley A, Lowe G, Steptoe A.

Prev Med. 2016 Dec;93:46-52. doi: 10.1016/j.ypmed.2016.09.018. Epub 2016 Sep 20.

19.

Evidence and Cost Effectiveness Requirements for Recommending New Biomarkers.

Collinson P.

EJIFCC. 2015 Aug 24;26(3):183-9. eCollection 2015 Aug. No abstract available.

20.

How Well Do Laboratories Adhere to Recommended Clinical Guidelines for the Management of Myocardial Infarction: The CARdiac MArker Guidelines Uptake in Europe Study (CARMAGUE).

Collinson P, Hammerer-Lercher A, Suvisaari J, Apple FS, Christenson RH, Pulkki K, van Dieijen-Visser MP, Duff CJ, Baum H, Stavljenic-Rukavina A, Aakre KM, Langlois MR, Stankovic S, Laitinen P; Working Group for Cardiac Markers, European Federation of Clinical Chemistry and Laboratory Medicine.

Clin Chem. 2016 Sep;62(9):1264-71. doi: 10.1373/clinchem.2016.259515. Epub 2016 Jul 26.

21.

High-sensitivity cardiac troponin at 3 hours: is the cat among the pigeons?

Body R, Collinson P, Goodacre S, Mills NL, Timmis A.

Heart. 2016 Aug 15;102(16):1253-4. doi: 10.1136/heartjnl-2016-309461. Epub 2016 Jun 20. No abstract available.

22.

The effect of multiple analysers on the biochemical diagnosis of myocardial infarction using a contemporary troponin-I assay.

Pethick J, Patel P, Davies T, Thompson J, Nallagonda M, Beech A, Collinson P, Lee V, Gupta P.

Ann Clin Biochem. 2016 Nov;53(6):702-705. doi: 10.1177/0004563216637388. Epub 2016 Sep 28.

PMID:
27099337
23.

High-sensitivity troponin measurements: challenges and opportunities for the laboratory and the clinician.

Collinson P.

Ann Clin Biochem. 2016 Mar;53(Pt 2):191-5. doi: 10.1177/0004563215619946. Epub 2015 Nov 13. No abstract available.

PMID:
26566666
24.

High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study.

Shah AS, Anand A, Sandoval Y, Lee KK, Smith SW, Adamson PD, Chapman AR, Langdon T, Sandeman D, Vaswani A, Strachan FE, Ferry A, Stirzaker AG, Reid A, Gray AJ, Collinson PO, McAllister DA, Apple FS, Newby DE, Mills NL; High-STEACS investigators.

Lancet. 2015 Dec 19;386(10012):2481-8. doi: 10.1016/S0140-6736(15)00391-8. Epub 2015 Oct 8.

25.

Type 2 myocardial infarction: the chimaera of cardiology?

Collinson P, Lindahl B.

Heart. 2015 Nov;101(21):1697-703. doi: 10.1136/heartjnl-2014-307122. Epub 2015 Jul 28. Review.

PMID:
26220812
26.

Detecting cardiac events - state-of-the-art.

Collinson P.

Ann Clin Biochem. 2015 Nov;52(Pt 6):702-4. doi: 10.1177/0004563215596761. Epub 2015 Jul 2.

PMID:
26139451
27.

The mediation of coronary calcification in the association between risk scores and cardiac troponin T elevation in healthy adults: Is atherosclerosis a good prognostic precursor of coronary disease?

Lazzarino AI, Hamer M, Carvalho L, Gaze D, Collinson P, Steptoe A.

Prev Med. 2015 Aug;77:150-4. doi: 10.1016/j.ypmed.2015.05.025. Epub 2015 Jun 4.

28.

The association between fibrinogen reactivity to mental stress and high-sensitivity cardiac troponin T in healthy adults.

Lazzarino AI, Hamer M, Gaze D, Collinson P, Rumley A, Lowe G, Steptoe A.

Psychoneuroendocrinology. 2015 Sep;59:37-48. doi: 10.1016/j.psyneuen.2015.05.002. Epub 2015 May 14.

29.

Age, sex, and racial influences on the Beckman Coulter AccuTnI+3 99th percentile.

Greene DN, Leong TK, Collinson PO, Kamer SM, Huang K, Lorey TS, Go AS.

Clin Chim Acta. 2015 Apr 15;444:149-53. doi: 10.1016/j.cca.2015.02.005. Epub 2015 Feb 12.

PMID:
25684454
30.

High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study.

Shah AS, Griffiths M, Lee KK, McAllister DA, Hunter AL, Ferry AV, Cruikshank A, Reid A, Stoddart M, Strachan F, Walker S, Collinson PO, Apple FS, Gray AJ, Fox KA, Newby DE, Mills NL.

BMJ. 2015 Jan 21;350:g7873. doi: 10.1136/bmj.g7873. Erratum in: BMJ. 2015;350:h626. Erratum in: BMJ. 2016 Sep 06;354:i4840.

31.

Serial changes in high-sensitivity cardiac troponin, N-terminal pro-B-type natriuretic peptide, and heart fatty acid binding protein during exercise echocardiography in patients with suspected angina pectoris and normal resting left ventricular function.

de Silva R, Tsujioka H, Gaze D, Banya WA, Shah BN, Zoppelaro G, Hersey J, Gonzalez AM, Collins P, Collinson PO, Senior R, Fox KM.

Clin Chem. 2015 Mar;61(3):554-6. doi: 10.1373/clinchem.2014.228536. Epub 2015 Jan 16. No abstract available.

32.

The clinical and diagnostic performance characteristics of the high sensitivity Abbott cardiac troponin I assay.

Collinson PO, Gaze D, Goodacre S.

Clin Biochem. 2015 Mar;48(4-5):275-81. doi: 10.1016/j.clinbiochem.2014.12.017. Epub 2014 Dec 27.

PMID:
25549978
33.

Comparison of conventional and high-sensitivity troponin in patients with chest pain: a collaborative meta-analysis.

Lipinski MJ, Baker NC, Escárcega RO, Torguson R, Chen F, Aldous SJ, Christ M, Collinson PO, Goodacre SW, Mair J, Inoue K, Lotze U, Sebbane M, Cristol JP, Freund Y, Chenevier-Gobeaux C, Meune C, Eggers KM, Pracoń R, Schreiber DH, Wu AH, Ordoñez-Llanos J, Jaffe AS, Twerenbold R, Mueller C, Waksman R.

Am Heart J. 2015 Jan;169(1):6-16.e6. doi: 10.1016/j.ahj.2014.10.007. Epub 2014 Oct 22.

PMID:
25497242
34.

Cardiac biomarkers - A short biography.

Collinson PO, Garrison L, Christenson RH.

Clin Biochem. 2015 Mar;48(4-5):197-200. doi: 10.1016/j.clinbiochem.2014.11.014. Epub 2014 Nov 22. No abstract available.

PMID:
25464015
35.

Type 2 myocardial infarction.

Collinson PO.

Heart. 2015 Jan;101(2):89-90. doi: 10.1136/heartjnl-2014-306865. Epub 2014 Nov 14. No abstract available.

PMID:
25398839
36.
37.

IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays.

Apple FS, Jaffe AS, Collinson P, Mockel M, Ordonez-Llanos J, Lindahl B, Hollander J, Plebani M, Than M, Chan MH; International Federation of Clinical Chemistry (IFCC) Task Force on Clinical Applications of Cardiac Bio-Markers.

Clin Biochem. 2015 Mar;48(4-5):201-3. doi: 10.1016/j.clinbiochem.2014.08.021. Epub 2014 Sep 7. Review.

PMID:
25204966
38.

Effects of nebivolol on biomarkers in elderly patients with heart failure.

Taneja AK, Gaze D, Coats AJ, Dumitrascu D, Spinarova L, Collinson P, Roughton M, Flather MD; SENIORS Investigators.

Int J Cardiol. 2014 Aug 1;175(2):253-60. doi: 10.1016/j.ijcard.2014.05.018. Epub 2014 May 17.

PMID:
24877590
39.

The role of cardiac biomarkers in cardiovascular disease risk assessment.

Collinson P.

Curr Opin Cardiol. 2014 Jul;29(4):366-71. doi: 10.1097/HCO.0000000000000081. Review.

PMID:
24848409
40.

A prospective study of the impact of serial troponin measurements on the diagnosis of myocardial infarction and hospital and six-month mortality in patients admitted to ICU with non-cardiac diagnoses.

Ostermann M, Lo J, Toolan M, Tuddenham E, Sanderson B, Lei K, Smith J, Griffiths A, Webb I, Coutts J, Chambers J, Collinson P, Peacock J, Bennett D, Treacher D.

Crit Care. 2014 Apr 4;18(2):R62. doi: 10.1186/cc13818.

41.

Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis.

Raskovalova T, Twerenbold R, Collinson PO, Keller T, Bouvaist H, Folli C, Giavarina D, Lotze U, Eggers KM, Dupuy AM, Chenevier-Gobeaux C, Meune C, Maisel A, Mueller C, Labarère J.

Eur Heart J Acute Cardiovasc Care. 2014 Mar;3(1):18-27. doi: 10.1177/2048872613514015. Epub 2013 Nov 20. Review.

42.

Cardiac biomarkers in heart failure.

Liquori ME, Christenson RH, Collinson PO, Defilippi CR.

Clin Biochem. 2014 Apr;47(6):327-37. doi: 10.1016/j.clinbiochem.2014.01.032. Epub 2014 Feb 12. Review.

PMID:
24530339
43.

Heart failure biomarkers at point-of-care: current utilization and future potential.

Christenson ES, Collinson PO, Defilippi CR, Christenson RH.

Expert Rev Mol Diagn. 2014 Mar;14(2):185-97. doi: 10.1586/14737159.2014.882772. Epub 2014 Feb 13. Review.

PMID:
24524847
44.

Analytical evaluation of the automated galectin-3 assay on the Abbott ARCHITECT immunoassay instruments.

Gaze DC, Prante C, Dreier J, Knabbe C, Collet C, Launay JM, Franekova J, Jabor A, Lennartz L, Shih J, del Rey JM, Zaninotto M, Plebani M, Collinson PO.

Clin Chem Lab Med. 2014 Jun;52(6):919-26. doi: 10.1515/cclm-2013-0942.

PMID:
24445238
46.

How to use C-reactive protein in acute coronary care.

Biasucci LM, Koenig W, Mair J, Mueller C, Plebani M, Lindahl B, Rifai N, Venge P, Hamm C, Giannitsis E, Huber K, Galvani M, Tubaro M, Collinson P, Alpert JS, Hasin Y, Katus H, Jaffe AS, Thygesen K; Study Group on Biomarkers in Cardiology of the Acute Cardiovascular Care Association of the European Society of Cardiology.

Eur Heart J. 2013 Dec;34(48):3687-90. doi: 10.1093/eurheartj/eht435. Epub 2013 Nov 7. No abstract available.

PMID:
24204013
47.

Reference ranges for cardiac troponin in the era of high sensitivity assays.

Collinson P.

Clin Biochem. 2013 Nov;46(16-17):1629-30. doi: 10.1016/j.clinbiochem.2013.10.007. No abstract available.

PMID:
24160455
48.

Measurement of natriuretic peptides at the point of care in the emergency and ambulatory setting: current status and future perspectives.

Bingisser R, Cairns CB, Christ M, Collinson P, Hausfater P, Lindahl B, Mair J, Price C, Venge P.

Am Heart J. 2013 Oct;166(4):614-621.e1. doi: 10.1016/j.ahj.2013.06.012. Epub 2013 Aug 15. Review.

PMID:
24093839
49.

The association between cortisol response to mental stress and high-sensitivity cardiac troponin T plasma concentration in healthy adults.

Lazzarino AI, Hamer M, Gaze D, Collinson P, Steptoe A.

J Am Coll Cardiol. 2013 Oct 29;62(18):1694-1701. doi: 10.1016/j.jacc.2013.05.070. Epub 2013 Jun 27.

50.

Randomised Assessment of Treatment using Panel Assay of Cardiac markers--Contemporary Biomarker Evaluation (RATPAC CBE).

Collinson PO, Gaze DC, Thokala P, Goodacre S.

Health Technol Assess. 2013;17(15):v-vi, 1-122. doi: 10.3310/hta17150.

Supplemental Content

Loading ...
Support Center